IRIS Accounts Production v24.3.0.553 06589575 Board of Directors 1.6.23 31.5.24 31.5.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 5794 1600 30233 19477 24445 23671 6 5794 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh065895752023-05-31065895752024-05-31065895752023-06-012024-05-31065895752022-05-31065895752022-06-012023-05-31065895752023-05-3106589575ns15:EnglandWales2023-06-012024-05-3106589575ns14:PoundSterling2023-06-012024-05-3106589575ns10:Director12023-06-012024-05-3106589575ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3106589575ns10:SmallEntities2023-06-012024-05-3106589575ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3106589575ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3106589575ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3106589575ns10:FullAccounts2023-06-012024-05-3106589575ns10:OrdinaryShareClass12023-06-012024-05-3106589575ns10:OrdinaryShareClass22023-06-012024-05-3106589575ns10:Director2422023-05-3106589575ns10:Director2422022-05-3106589575ns10:Director2422023-06-012024-05-3106589575ns10:Director2422022-06-012023-05-3106589575ns10:Director2422024-05-3106589575ns10:Director2422023-05-3106589575ns5:CurrentFinancialInstruments2024-05-3106589575ns5:CurrentFinancialInstruments2023-05-3106589575ns5:ShareCapital2024-05-3106589575ns5:ShareCapital2023-05-3106589575ns5:RetainedEarningsAccumulatedLosses2024-05-3106589575ns5:RetainedEarningsAccumulatedLosses2023-05-3106589575ns10:RegisteredOffice2023-06-012024-05-3106589575ns5:FurnitureFittings2023-05-3106589575ns5:FurnitureFittings2023-06-012024-05-3106589575ns5:FurnitureFittings2024-05-3106589575ns5:FurnitureFittings2023-05-3106589575ns10:OrdinaryShareClass12024-05-3106589575ns10:OrdinaryShareClass22024-05-3106589575ns10:Director22023-06-012024-05-31065895751ns10:Director12023-05-31065895751ns10:Director12022-05-31065895751ns10:Director12023-06-012024-05-31065895751ns10:Director12022-06-012023-05-31065895751ns10:Director12024-05-31065895751ns10:Director12023-05-31
REGISTERED NUMBER: 06589575 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st May 2024

for

Sushruth Diagnostics Ltd

Sushruth Diagnostics Ltd (Registered number: 06589575)






Contents of the Financial Statements
for the Year Ended 31st May 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Sushruth Diagnostics Ltd (Registered number: 06589575)

Balance Sheet
31st May 2024

31.5.24 31.5.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 6,917 10,011

CURRENT ASSETS
Debtors 5 137,500 137,500
Cash at bank 321,605 351,744
459,105 489,244
CREDITORS
Amounts falling due within one year 6 5,017 22,989
NET CURRENT ASSETS 454,088 466,255
TOTAL ASSETS LESS CURRENT
LIABILITIES

461,005

476,266

PROVISIONS FOR LIABILITIES 1,258 1,902
NET ASSETS 459,747 474,364

CAPITAL AND RESERVES
Called up share capital 7 200 200
Retained earnings 459,546 474,162
SHAREHOLDERS' FUNDS 459,746 474,362

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25th February 2025 and were signed on its behalf by:





Dr K Subramanian - Director



Sushruth Diagnostics Ltd (Registered number: 06589575)

Balance Sheet - continued
31st May 2024

** STATEMENT OF FINANCIAL POSITION - CURRENT YEAR - DOES NOT BALANCE - PLEASE CHECK THAT ALL POSTINGS HAVE BEEN MADE TO ACCOUNTS USED ON LIMITED COMPANY REPORTS
** STATEMENT OF FINANCIAL POSITION - LAST YEAR - DOES NOT BALANCE - PLEASE CHECK THAT ALL POSTINGS HAVE BEEN MADE TO ACCOUNTS USED ON LIMITED COMPANY REPORTS

Sushruth Diagnostics Ltd (Registered number: 06589575)

Notes to the Financial Statements
for the Year Ended 31st May 2024

1. COMPANY INFORMATION

Sushruth Diagnostics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06589575

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Sushruth Diagnostics Ltd (Registered number: 06589575)

Notes to the Financial Statements - continued
for the Year Ended 31st May 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st June 2023 18,514
Additions 839
At 31st May 2024 19,353
DEPRECIATION
At 1st June 2023 8,503
Charge for year 3,933
At 31st May 2024 12,436
NET BOOK VALUE
At 31st May 2024 6,917
At 31st May 2023 10,011

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Inter company Loan 137,500 137,500

Other debtors relates to an inter-company loan to Sushruth Limited.

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.24 31.5.23
£    £   
Corporation tax payable 2,776 14,041
Social security 583 619
Directors' current accounts 6 5,794
Accrued expenses 1,652 2,535
5,017 22,989

Sushruth Diagnostics Ltd (Registered number: 06589575)

Notes to the Financial Statements - continued
for the Year Ended 31st May 2024

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.24 31.5.23
value: £    £   
100 Ordinary A 1 100 100
100 Ordinary B 1 100 100
200 200

The Ordinary A Shares rank equally in terms of voting rights, rights to participate in all dividend distributions and rights to participate in any capital distributions on winding up.

The Ordinary B Shares do not hold any voting rights and dividend rights are at the discretion of the Ordinary A Shareholders.

The Ordinary A and Ordinary B Shares rank pari passu in respect of capital distribution rights.

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st May 2024 and 31st May 2023:

31.5.24 31.5.23
£    £   
Dr K Subramanian and Mrs R Kumar
Balance outstanding at start of year (5,794 ) (1,600 )
Amounts advanced 30,233 19,477
Amounts repaid (24,445 ) (23,671 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (6 ) (5,794 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr K Subramanian by virtue of his 100% holding of the voting share capital.